Literature DB >> 19084976

"Necklace" fibers, a new histological marker of late-onset MTM1-related centronuclear myopathy.

Jorge A Bevilacqua1, Marc Bitoun, Valérie Biancalana, Anders Oldfors, Gisela Stoltenburg, Kristl G Claeys, Emmanuelle Lacène, Guy Brochier, Linda Manéré, Pascal Laforêt, Bruno Eymard, Pascale Guicheney, Michel Fardeau, Norma Beatriz Romero.   

Abstract

Mutations in the gene encoding the phosphoinositide phosphatase myotubularin 1 protein (MTM1) are usually associated with severe neonatal X-linked myotubular myopathy (XLMTM). However, mutations in MTM1 have also been recognized as the underlying cause of "atypical" forms of XLMTM in newborn boys, female infants, female manifesting carriers and adult men. We reviewed systematically the biopsies of a cohort of patients with an unclassified form of centronuclear myopathy (CNM) and identified four patients presenting a peculiar histological alteration in some muscle fibers that resembled a necklace ("necklace fibers"). We analyzed further the clinical and morphological features and performed a screening of the genes involved in CNM. Muscle biopsies in all four patients demonstrated 4-20% of fibers with internalized nuclei aligned in a basophilic ring (necklace) at 3 microm beneath the sarcolemma. Ultrastructurally, such necklaces consisted of myofibrils of smaller diameter, in oblique orientation, surrounded by mitochondria, sarcoplasmic reticulum and glycogen granules. In the four patients (three women and one man), myopathy developed in early childhood but was slowly progressive. All had mutations in the MTM1 gene. Two mutations have previously been reported (p.E404K and p.R241Q), while two are novel; a c.205_206delinsAACT frameshift change in exon 4 and a c.1234A>G mutation in exon 11 leading to an abnormal splicing and the deletion of nine amino acids in the catalytic domain of MTM1. Necklace fibers were seen neither in DNM2- or BIN1-related CNM nor in males with classical XLMTM. The presence of necklace fibers is useful as a marker to direct genetic analysis to MTM1 in CNM.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 19084976     DOI: 10.1007/s00401-008-0472-1

Source DB:  PubMed          Journal:  Acta Neuropathol        ISSN: 0001-6322            Impact factor:   17.088


  33 in total

1.  Modeling the human MTM1 p.R69C mutation in murine Mtm1 results in exon 4 skipping and a less severe myotubular myopathy phenotype.

Authors:  Christopher R Pierson; Ashley N Dulin-Smith; Ashley N Durban; Morgan L Marshall; Jordan T Marshall; Andrew D Snyder; Nada Naiyer; Jordan T Gladman; Dawn S Chandler; Michael W Lawlor; Anna Buj-Bello; James J Dowling; Alan H Beggs
Journal:  Hum Mol Genet       Date:  2011-11-07       Impact factor: 6.150

2.  Clinical utility gene card for: Centronuclear and myotubular myopathies.

Authors:  Valérie Biancalana; Alan H Beggs; Soma Das; Heinz Jungbluth; Wolfram Kress; Ichizo Nishino; Kathryn North; Norma B Romero; Jocelyn Laporte
Journal:  Eur J Hum Genet       Date:  2012-05-23       Impact factor: 4.246

3.  Intravenous Administration of a MTMR2-Encoding AAV Vector Ameliorates the Phenotype of Myotubular Myopathy in Mice.

Authors:  Nathalie Danièle; Christelle Moal; Laura Julien; Martina Marinello; Thibaud Jamet; Samia Martin; Alban Vignaud; Michael W Lawlor; Ana Buj-Bello
Journal:  J Neuropathol Exp Neurol       Date:  2018-04-01       Impact factor: 3.685

4.  Characterization and genetic diagnosis of centronuclear myopathies in seven Chinese patients.

Authors:  Yan Zhao; Zhe Zhao; Hongrui Shen; Qi Bing; Jing Hu
Journal:  Neurol Sci       Date:  2018-09-19       Impact factor: 3.307

5.  MTM1 mutation associated with X-linked myotubular myopathy in Labrador Retrievers.

Authors:  Alan H Beggs; Johann Böhm; Elizabeth Snead; Marek Kozlowski; Marie Maurer; Katie Minor; Martin K Childers; Susan M Taylor; Christophe Hitte; James R Mickelson; Ling T Guo; Andrew P Mizisin; Anna Buj-Bello; Laurent Tiret; Jocelyn Laporte; G Diane Shelton
Journal:  Proc Natl Acad Sci U S A       Date:  2010-08-03       Impact factor: 11.205

Review 6.  Congenital myopathies: an update.

Authors:  Jessica R Nance; James J Dowling; Elizabeth M Gibbs; Carsten G Bönnemann
Journal:  Curr Neurol Neurosci Rep       Date:  2012-04       Impact factor: 5.081

7.  Sporadic centronuclear myopathy with muscle pseudohypertrophy, neutropenia, and necklace fibers due to a DNM2 mutation.

Authors:  Teerin Liewluck; Tracy L Lovell; Anna V Bite; Andrew G Engel
Journal:  Neuromuscul Disord       Date:  2010-12       Impact factor: 4.296

8.  Adult MTM1-related myopathy carriers: Classification based on deep phenotyping.

Authors:  Benjamin T Cocanougher; Lauren Flynn; Pomi Yun; Minal Jain; Melissa Waite; Ruhi Vasavada; Jason D Wittenbach; Sabine de Chastonay; Sameer Chhibber; A Micheil Innes; Linda MacLaren; Tahseen Mozaffar; Andrew E Arai; Sandra Donkervoort; Carsten G Bönnemann; A Reghan Foley
Journal:  Neurology       Date:  2019-09-20       Impact factor: 9.910

9.  Clinical and Pathological Features of Korean Patients with DNM2-Related Centronuclear Myopathy.

Authors:  Young-Eun Park; Young-Chul Choi; Jong-Suk Bae; Chang-Hoon Lee; Hyang-Suk Kim; Jin-Hong Shin; Dae-Seong Kim
Journal:  J Clin Neurol       Date:  2014-01-06       Impact factor: 3.077

10.  Expanding the MTM1 mutational spectrum: novel variants including the first multi-exonic duplication and development of a locus-specific database.

Authors:  Jorge Oliveira; Márcia E Oliveira; Wolfram Kress; Ricardo Taipa; Manuel Melo Pires; Pascale Hilbert; Peter Baxter; Manuela Santos; Henk Buermans; Johan T den Dunnen; Rosário Santos
Journal:  Eur J Hum Genet       Date:  2012-09-12       Impact factor: 4.246

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.